MGTX MeiraGTx Holdings PLC

USD 4.99 0.11 2.254098
Icon

MeiraGTx Holdings PLC (MGTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 4.99

+0.11 (+2.25)%

USD 0.31B

0.15M

N/A

N/A

Icon

MGTX

MeiraGTx Holdings PLC (USD)
COMMON STOCK | NSD
USD 4.99
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.31B

N/A

USD 4.99

MeiraGTx Holdings PLC (MGTX) Stock Forecast

N/A

Based on the MeiraGTx Holdings PLC stock forecast from 0 analysts, the average analyst target price for MeiraGTx Holdings PLC is not available over the next 12 months. MeiraGTx Holdings PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of MeiraGTx Holdings PLC is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, MeiraGTx Holdings PLC’s stock price was USD 4.99. MeiraGTx Holdings PLC’s stock price has changed by +2.67% over the past week, -14.11% over the past month and -3.85% over the last year.

No recent analyst target price found for MeiraGTx Holdings PLC
No recent average analyst rating found for MeiraGTx Holdings PLC

Company Overview MeiraGTx Holdings PLC

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegene...Read More

https://meiragtx.com

450 East 29th Street, New York, NY, United States, 10016

419

December

USD

USA

Adjusted Closing Price for MeiraGTx Holdings PLC (MGTX)

Loading...

Unadjusted Closing Price for MeiraGTx Holdings PLC (MGTX)

Loading...

Share Trading Volume for MeiraGTx Holdings PLC Shares

Loading...

Compare Performance of MeiraGTx Holdings PLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for MGTX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To MeiraGTx Holdings PLC (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +9.33 (+2.38%) USD102.73B 28.66 20.00

ETFs Containing MGTX

Symbol Name MGTX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About MeiraGTx Holdings PLC (MGTX) Stock

Stock Target Advisor's fundamental analysis for MeiraGTx Holdings PLC's stock is Bearish.

Unfortunately we do not have enough data on MGTX's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on MGTX's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on MGTX's stock to indicate if its overvalued.

The last closing price of MGTX's stock was USD 4.99.

The most recent market capitalization for MGTX is USD 0.31B.

Unfortunately we do not have enough analyst data on MGTX's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains MeiraGTx Holdings PLC's stock.

As per our most recent records MeiraGTx Holdings PLC has 419 Employees.

MeiraGTx Holdings PLC's registered address is 450 East 29th Street, New York, NY, United States, 10016. You can get more information about it from MeiraGTx Holdings PLC's website at https://meiragtx.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...